Clinical Presentation and Outcomes in Patients at Risk of Type II Myocardial InfarctioN in the emerGency Department. (COMING)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03953651|
Recruitment Status : Not yet recruiting
First Posted : May 16, 2019
Last Update Posted : May 16, 2019
Type 2 myocardial infarction has been reported in the Universal Definition of Myocardial Infarction for more than 10 years and most studies resulted in a high mortality rate. However, little to nothing is known for both criteria to define myocardial oxygenation imbalance threshold and the outcome of these patients presenting with myocardial oxygenation imbalance.
The aim of this study is to compare the outcome at 6 months for patients admitted in the emergency department with a myocardial oxygenation imbalance, depending on whether a type 2 myocardial infarction occured or not.
|Condition or disease||Intervention/treatment|
|Myocardial Oxygenation Imbalance Myocardial Infarction||Other: Follow-up|
|Study Type :||Observational|
|Estimated Enrollment :||1000 participants|
|Official Title:||Clinical Presentation and Outcomes in Patients at Risk of Type II Myocardial InfarctioN in the emerGency Department.|
|Estimated Study Start Date :||May 31, 2019|
|Estimated Primary Completion Date :||April 30, 2020|
|Estimated Study Completion Date :||May 31, 2020|
Patients admitted in the emergency department presenting a myocardial oxygenation imbalance and are therefore at risk for Myocardial Infarction (MI) type 2.
Onset of Major Adverse Cardiovascular Event of death from all causes will be collected at 3 and 6 months after inclusion.
- Onset of a Major Adverse Cardiovascular Event at 6 months [ Time Frame: 6 months ]
Onset of a Major Adverse Cardiovascular Event such as:
- Cardiovascular death
- Non fatal myocardial infarction
- Admission for acute heart failure
- Non fatal stroke
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03953651
|Contact: Laurent JACQUIN, Dr||4 72 11 69 47 ext 33||EH_recherche_urgences@chu-lyon.fr|
|Principal Investigator:||Laurent JACQUIN, Dr||Hospices Civils de Lyon|